Pay in 4 interest-free payments of $6.87 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
AIChE J
doi:10.1016/j.lfs.2019.117139 Park JR, Lee H, Kim SI, Yang SR
Back to Journals Diabetes, Metabolic Syndrome and Obesity Volume 15 The Emerging Role of Dual GLP-1 and GIP Receptor Agonists in Glycemic Management and Cardiovascular Risk Reduction Received 20 January 2022 Accepted for publication 18 March 2022 Published 5 April 2022 Volume 2022:15 Pages 10231030 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Prof
The consistency across dose groups is telling
%25201.png)
US$ 25.32
US$ 21.88
US$ 20.99
US$ 26.06
